** Shares of Recce Pharmaceuticals RCE.AX fall 7.7% to A$0.300, their lowest levels since April 2, 2020
** The pharmaceutical co announces a placement of A$5 million ($3.06 million) and an entitlement offer of A$10.8 million to fund clinical trials in Indonesia and Australia
** Issue price of A$0.28 for the placement represents a 13.8% discount to co's last close
** Stock down ~38% YTD, including current session's moves
($1 = 1.6332 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.